WPPB

Jon Hamilton

Jon Hamilton is a correspondent for NPR's Science Desk. Currently he focuses on neuroscience, health risks, and extreme weather.

Following the 2011 earthquake and tsunami in Japan, Hamilton was part of NPR's team of science reporters and editors who went to Japan to cover the crisis at the Fukushima Dai-ichi nuclear power plant.

Hamilton contributed several pieces to the Science Desk series "The Human Edge," which looked at what makes people the most versatile and powerful species on Earth. His reporting explained how humans use stories, how the highly evolved human brain is made from primitive parts, and what autism reveals about humans social brains.

In 2009, Hamilton received the Michael E. DeBakey Journalism Award for his piece on the neuroscience behind treating autism.

Before joining NPR in 1998, Hamilton was a media fellow with the Henry J. Kaiser Family Foundation studying health policy issues. He reported on states that have improved their Medicaid programs for the poor by enrolling beneficiaries in private HMOs.

From 1995-1997, Hamilton wrote on health and medical topics as a freelance writer, after having been a medical reporter for both The Commercial Appeal and Physician's Weekly.

Hamilton graduated with honors from Oberlin College in Ohio with a Bachelor of Arts degree in English. As a student, he was the editor of the Oberlin Review student newspaper. He earned his master's degree in journalism from Columbia University, where he graduated with honors During his time at Columbia, Hamilton was awarded the Baker Prize for magazine writing and earned a Sherwood traveling fellowship.

Government scientists have presented new evidence that the plastic additive BPA isn't a health threat.

Low doses of the chemical given to hundreds of rats, "did not elicit clear, biologically plausible adverse effects," said K. Barry Delclos, a research pharmacologist at the Food and Drug Administration's National Center for Toxicological Research.

Kids with ADHD are easily distracted. Barn owls are not.

So a team at Johns Hopkins University in Baltimore is studying these highly focused predatory birds in an effort to understand the brain circuits that control attention.

The team's long-term goal is to figure out what goes wrong in the brains of people with attention problems, including attention deficit hyperactivity disorder.

A new study suggests that ketamine, an increasingly popular treatment for depression, has something in common with drugs like fentanyl and oxycodone.

The small study found evidence that ketamine's effectiveness with depression, demonstrated in many small studies over the past decade, comes from its interaction with the brain's opioid system. A Stanford University team reported their findings Wednesday in The American Journal of Psychiatry.

Scientists have taken another step toward understanding what makes the human brain unique.

An international team has identified a kind of brain cell that exists in people but not mice, the team reported Monday in the journal Nature Neuroscience.

Daniel, a Marine Corps veteran, used to fire a rocket launcher called the shoulder-launched multipurpose assault weapon. Two decades later, he still experiences dizzy spells and disorientation. But the Department of Veterans Affairs doesn't have a category for vets like him, who may have sustained traumatic brain injuries from training rather than combat.

Read Daniel's full story on NPR's health blog, Shots.

Pages